Trending Now
Features
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
More
Philippines first country to grant permit for use of Sepsivac for...
Ahmedabad, September 21, 2021: The Philippines has become the first country to grant the emergency permit for use of Sepsivac, developed by Ahmedabad-based Cadila...
Sirona’s menstrual cup wash and sterilizer to make menstrual hygiene a...
The menstrual cup wash cleanses the cup without leaving any residue or irritants
The menstrual cup sterilizer rids it of 99.9% germs in...
Medical Tourism
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
More
POPULAR NEWS
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
More
Biotechnology
MGM Healthcare’s Heart and Lung Transplant Team Performs an ABO-Incompatible Paediatric Heart Transplant on...
CHENNAI, August 23 , 2023 : MGM Healthcare is proud to announce the successful completion of an ABO-incompatible Paediatric Heart Transplant, crossing the blood...
ESDS launches AA+ Covid 19 testing solution that indicates disease in less than 5...
Nashik, May 20, 2020: One of India’s leading IT Solution company, ESDS Software Solution Pvt. Ltd. has come up with a rapid COVID-19 detection solution,...
IT & Software Support
Wipro GE Healthcare keen to make diagnostics affordable to all
Wipro GE Healthcare is keen to invest in technologies that are affordable to all.
Terri Bresenhem, President and Chief Executive, GE Healthcare, told reporters here on Wednesday that the company has not only been expanding its presence in India for over two decades now, but investing at least 30 per cent more in recent years. “The investment is both in terms of manpower and strengthening our research and development facility,” she said.
INDIA MANUFACTURE
“We are striving to make healthcare affordable to all. While most medical equipment companies that have established their presence here import close to 80 per cent of their equipment, our import component is less. At GE Healthcare, we design and manufacture 30 per cent of the equipment in India. We have a strong research team, high quality thinkers and innovators here,” she added.
Appointments
Takeda appoints Serina Fischer as the General Manager for India
New Delhi, March 03, 2022: Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, announced the appointment of Serina Fischer as its General Manager...
Financial Results
Syngene reports solid Q4 growth and ends the year on a strong note
Q4 revenue up 13% to Rs. 628 Cr, PAT up 20% to Rs 120...
Aster DM Healthcare Q1 FY22 consolidated revenue up by 36% to Rs. 2,372 Crs., EBITDA up by 97% to Rs. 281 Crs. over Q1...
India operations revenue up by 84% to Rs. 550 Crs. and EBITDA up by 460%...
Clinical Trails
Amidst the ongoing Covid-19 pandemic ISSAR Pharma announces out-licensing of its peptide-based NCEs
ISSAR Pharma, the only company in India which focuses on research and development of New Chemical Entities (NCE), is licensing out its NCEs based...
Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...
Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.
Bulk Drug
Health Care
Alternative Medicine
Eye Care
Unlocking Vision Wellness: Allergan’s Media Conclave on World Sight Day Spotlights Eyecare’s Crucial Role...
New Delhi, October 12, 2023 : This World Sight Day, Allergan, an AbbVie company, came together with renowned experts in the field of ophthalmology...
Latest News
Aster CMI doctors revive 51-year-old covid-19 patient after 3 cardiac arrests
Bangalore, September 23, 2020: In a case that provides hope for the treatment of patients suffering from covid19, medical specialists at Aster CMI Hospital successfully...
Vitafoods Asia Conference to present top 5 APAC nutraceutical trends
The conference programme for Vitafoods Asia 2019 will cover 5 key themes shaping the Asia Pacific region and equip visitors with practical outcomes to...
Dr. Agarwal’s Health Care Ltd. raises over 1,000 Crore funding from TPG Growth and...
The investment round is India's largest fund raise in eyecare space
Company intends to double the current network of 105 hospitals to over...
Dental Care
Hospital Management
Drug Discovery & Development
Suppliers
Technology
Shining a Light on Laser-Based Therapy
Researchers reveal early response of tumor vessels to anti-cancer therapy
New Delhi, September 04, 2020: Vascular-targeted photodynamic therapy (VTP) with TOOKAD®, a therapeutic platform for solid...
Companies
Green Energy conference 2019
International Conference Green Energy and Recycling warmly welcomes each one of the individuals and supporters from worldwide to attend during December 02-03, 2019 in...